ASPEN AEROGELS INC(ASPN)— Stock Profile, AI Score & Financials

Consumer Discretionary · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

ASPEN AEROGELS INC (ASPN) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Discretionary sector company. 13F Pro's AI-powered ranking engine scores ASPN at 28.6/100 on a 32-signal composite quality model, placing it at rank #2,552 of 2,962 stocks — the bottom half of the AI-ranked universe. ASPN scores in the top quartile across institutional flow (76.3). Areas of concern include revenue growth (3.4) and balance sheet strength (8.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 31.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ASPEN AEROGELS INC reports quarterly revenue of $49.8M, net income of $-23.3M, free cash flow of $-18.0M. Top institutional holders of ASPN by reported 13-F value include KIM, BlackRock, OAKTOP CAPITAL MANAGEMENT II, L.P., based on the most recent SEC filings. ASPN trades on the NYSE exchange and files with the SEC under CIK 1145986. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ASPN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASPEN AEROGELS INC directly from SEC EDGAR.

AI Quality Score

28.6/100

AI Rank

#2,552

Revenue

$49.8M

Net Income

$-23.3M

Free Cash Flow

$-18.0M

ASPN key financials by period

ASPEN AEROGELS INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K/A$271.1M$-389.6M-139.5%
FY 202410-K/A$452.7M$13.4M12.0%
FY 202310-K/A$238.7M$-45.8M-20.6%
FY 202210-K$180.4M$-82.7M-43.9%
FY 202110-K$121.6M$-37.1M-33.4%
FY 202010-K$100.3M$-21.8M-21.5%

Institutions holding ASPN

Institutional investors reporting a position in ASPEN AEROGELS INC on SEC Form 13F.
InstitutionSharesValueReported
KIM12,280,426$77.9M2026-06-30
BlackRock5,277,148$33.5M2026-06-30
OAKTOP CAPITAL MANAGEMENT II, L.P.5,168,674$32.8M2026-06-30
VANGUARD CAPITAL MANAGEMENT3,539,271$22.4M2026-06-30
NEEDHAM INVESTMENT MANAGEMENT3,260,800$20.7M2026-06-30
GEORGE KAISER FAMILY FOUNDATION3,167,322$20.1M2026-06-30
STATE STREET2,559,495$16.2M2026-06-30
AMERICAN CENTURY COMPANIES2,510,042$15.9M2026-06-30
JACOBS LEVY EQUITY MANAGEMENT2,058,083$13.0M2026-06-30
AMERIPRISE FINANCIAL1,821,295$11.5M2026-06-30
ASPN

ASPEN AEROGELS INC

ASPN
NYSESmall CapConsumer Discretionary

13F Pro Quality Score

28.6/100

Rank #2,552 of 2,962 stocks

View Consumer Discretionary peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

3.4/100

Profitability

10.0/100

Balance Sheet

8.5/100

Earnings Quality

17.4/100

Free Cash Flow

68.3/100

Institutional Flow

76.3/100

Revenue Scale

23.8/100

Dilution Risk

31.1/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$49.85M

Net Income

Q2 2026
EDGAR

$-23.26M

EPS (Diluted)

Q2 2026
EDGAR

$-0.28

ROIC

Q2 2026
EDGAR

-42.2%

Free Cash Flow

Q2 2026
EDGAR

$-18.00M

Debt/Equity

Q2 2026
EDGAR

0.42

Top Institutional Holders

as of Q2 2026
$471.67M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…